Detecting Endometrial Cancer by Blood Spectroscopy: A Diagnostic Cross-Sectional Study.
blood diagnostics
endometrial cancer
screening
spectroscopy
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
16 May 2020
16 May 2020
Historique:
received:
09
04
2020
revised:
07
05
2020
accepted:
12
05
2020
entrez:
21
5
2020
pubmed:
21
5
2020
medline:
21
5
2020
Statut:
epublish
Résumé
Endometrial cancer is the sixth most common cancer in women, with a rising incidence worldwide. Current approaches for the diagnosis and screening of endometrial cancer are invasive, expensive or of moderate diagnostic accuracy, limiting their clinical utility. There is a need for cost-effective and minimally invasive approaches to facilitate the early detection and timely management of endometrial cancer. We analysed blood plasma samples in a cross-sectional diagnostic accuracy study of women with endometrial cancer (
Identifiants
pubmed: 32429365
pii: cancers12051256
doi: 10.3390/cancers12051256
pmc: PMC7281323
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Department of Health
ID : NIHR-CS-012-009
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 098670/Z/12/Z
Pays : United Kingdom
Organisme : National Institute for Health Research
ID : NIHR-CS-012-009
Organisme : Medical Research Council
ID : MR/M018431/1
Pays : United Kingdom
Organisme : National Institute for Health Research
ID : IS-BRC-1215-20007
Organisme : Genesis Research Trust
ID : P63522 WSCR
Organisme : Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
ID : 88881.128982/2016-01
Références
J Natl Cancer Inst. 2018 Apr 1;110(4):354-361
pubmed: 29045681
Nat Rev Clin Oncol. 2011 Mar;8(3):142-50
pubmed: 21364687
BMJ. 2011 Jul 06;343:d3954
pubmed: 21734165
Int J Cancer. 2013 Apr 1;132(7):1633-45
pubmed: 22987275
BMJ. 2017 Feb 28;356:j477
pubmed: 28246088
Clin Chim Acta. 2018 Jul;482:215-223
pubmed: 29630870
Gynecol Oncol Rep. 2018 Aug 23;26:109-110
pubmed: 30533477
BMC Cancer. 2015 May 12;15:396
pubmed: 25964114
Obstet Gynecol. 2010 Jul;116(1):160-7
pubmed: 20567183
Gynecol Oncol. 2017 Feb;144(2):324-328
pubmed: 27912906
Analyst. 2013 Jul 21;138(14):3917-26
pubmed: 23325355
Nat Protoc. 2010 Nov;5(11):1748-60
pubmed: 21030951
Ceska Gynekol. 2013 Nov;78(5):448-59
pubmed: 24313431
Mass Spectrom Rev. 2018 Mar;37(2):107-138
pubmed: 27276657
Lancet. 2016 Mar 12;387(10023):1094-1108
pubmed: 26354523
Science. 2018 Feb 23;359(6378):926-930
pubmed: 29348365
Nat Commun. 2019 Oct 8;10(1):4501
pubmed: 31594931
PLoS One. 2016 Nov 9;11(11):e0165539
pubmed: 27829038
Eur J Obstet Gynecol Reprod Biol. 2017 Jun;213:71-97
pubmed: 28437632
Sci Rep. 2017 Apr 07;7:44808
pubmed: 28387226
Int J Cancer. 2019 Feb 1;144(3):641-650
pubmed: 30289975
Cancer Epidemiol Biomarkers Prev. 2010 Dec;19(12):3119-30
pubmed: 21030602
Oncol Lett. 2013 Jul;6(1):261-267
pubmed: 23946815
Health Technol Assess. 2014 Apr;18(24):1-201, v-vi
pubmed: 24767431
Rapid Commun Mass Spectrom. 2009 Mar;23(6):863-76
pubmed: 19224569
JAMA Oncol. 2017 Dec 1;3(12):1702-1706
pubmed: 28772289
OMICS. 2014 Aug;18(8):513-23
pubmed: 24937213
Nat Protoc. 2014 Aug;9(8):1771-91
pubmed: 24992094
Mol Oncol. 2012 Apr;6(2):140-6
pubmed: 22356776
Int J Mol Sci. 2013 Sep 13;14(9):18925-58
pubmed: 24065096
Lancet Public Health. 2019 Nov;4(11):e551
pubmed: 31562068
Proc Natl Acad Sci U S A. 2017 Sep 19;114(38):E7929-E7938
pubmed: 28874525
Cancer Epidemiol Biomarkers Prev. 2007 Feb;16(2):276-80
pubmed: 17301260
Anal Chem. 2017 May 16;89(10):5238-5245
pubmed: 28409627
PLoS One. 2014 Oct 20;9(10):e110767
pubmed: 25329674
Breast Cancer (Auckl). 2016 Nov 13;10:191-196
pubmed: 27867299
Ann Oncol. 2011 Apr;22(4):884-9
pubmed: 20937645
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
Am J Obstet Gynecol. 2010 Jan;202(1):73.e1-5
pubmed: 19766980
Lancet Oncol. 2011 Jan;12(1):38-48
pubmed: 21147030
Geburtshilfe Frauenheilkd. 2015 Feb;75(2):135-136
pubmed: 25797956
Lancet Oncol. 2001 Nov;2(11):698-704
pubmed: 11902541